Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22551447 | 0.98 | OPRM1 (0.31) | OPRM1 | |
| SCHEMBL22551438 | 0.87 | OPRM1 (0.31) | OPRM1 | |
| SCHEMBL22551511 | 0.85 | SMPD1 (0.31) | OPRM1 | |
| SCHEMBL22551471 | 0.85 | — | — | |
| SCHEMBL22551515 | 0.83 | ZDHHC7 (0.31) | — | |
| SCHEMBL305600 | 0.80 | OPRM1 (0.42) | OPRM1 | |
| SCHEMBL22551434 | 0.78 | ZDHHC7 (0.35) | — | |
| SCHEMBL2580819 | 0.78 | OPRM1 (0.41) | OPRM1 | |
| SCHEMBL1109616 | 0.78 | OPRM1 (0.41) | OPRM1 | |
| SCHEMBL137959 | 0.78 | OPRM1 (0.41) | OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11739184-B2 | Polysiloxazane compound having alkoxysilyl group, process for producing same, and composition and cured product including same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-08-29 | — | — | US | disclosed |
| US-11708460-B2 | Alkoxysilyl group-containing organic silazane compound, method for producing same, composition containing same and cured product | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-07-25 | — | — | US | disclosed |
| EP-3798252-B1 | POLYSILOXAZANE COMPOUND HAVING ALKOXYSILYL GROUP, PROCESS FOR PRODUCING SAME, AND COMPOSITION AND CURED PRODUCT INCLUDING SAME | SHINETSU CHEMICAL CO (JP) | 2022-06-29 | — | — | EP | disclosed |
| US-20210095079-A1 | POLYSILOXAZANE COMPOUND HAVING ALKOXYSILYL GROUP, PROCESS FOR PRODUCING SAME, AND COMPOSITION AND CURED PRODUCT INCLUDING SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-04-01 | — | — | US | disclosed |
| EP-3798252-A1 | POLYSILOXAZANE COMPOUND HAVING ALKOXYSILYL GROUP, PROCESS FOR PRODUCING SAME, AND COMPOSITION AND CURED PRODUCT INCLUDING SAME | Shin-Etsu Chemical Co., Ltd. (JP) | 2021-03-31 | — | — | EP | disclosed |
| CN-111825710-A | Organosilazane compounds containing alkoxysilyl groups, process for their preparation, compositions containing them and cured products | 信越化学工业株式会社 | 2020-10-27 | — | — | CN | disclosed |
| US-20200332071-A1 | ALKOXYSILYL GROUP-CONTAINING ORGANIC SILAZANE COMPOUND, METHOD FOR PRODUCING SAME, COMPOSITION CONTAINING SAME AND CURED PRODUCT | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-10-22 | — | — | US | disclosed |
| EP-3725822-A1 | ALKOXYSILYL GROUP-CONTAINING ORGANIC SILAZANE COMPOUND, METHOD FOR PRODUCING SAME, COMPOSITION CONTAINING SAME AND CURED PRODUCT | Shin-Etsu Chemical Co., Ltd. (JP) | 2020-10-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11708460-B2 | Alkoxysilyl group-containing organic silazane compound, method for producing same, composition containing same and cured product | OR10J3, ALKBH1, ALKBH2 | OPRM1 541/4885 |
| US-20200332071-A1 | ALKOXYSILYL GROUP-CONTAINING ORGANIC SILAZANE COMPOUND, METHOD FOR PRODUCING SAME, COMPOSITION CONTAINING SAME AND CURED PRODUCT | OR10J3, ALKBH1, ALKBH2 | OPRM1 541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.